Mikio Igawa

5.5k total citations
175 papers, 4.1k citations indexed

About

Mikio Igawa is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mikio Igawa has authored 175 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 62 papers in Pulmonary and Respiratory Medicine and 59 papers in Molecular Biology. Recurrent topics in Mikio Igawa's work include Bladder and Urothelial Cancer Treatments (40 papers), Prostate Cancer Treatment and Research (26 papers) and Urological Disorders and Treatments (24 papers). Mikio Igawa is often cited by papers focused on Bladder and Urothelial Cancer Treatments (40 papers), Prostate Cancer Treatment and Research (26 papers) and Urological Disorders and Treatments (24 papers). Mikio Igawa collaborates with scholars based in Japan, United States and Sweden. Mikio Igawa's co-authors include Hiroaki Shiina, Shinji Urakami, Rajvir Dahiya, Kazushi Shigeno, Nobuyuki Kikuno, Hideki Enokida, Tatsuaki Yoneda, Yuichiro Tanaka, Toshifumi Kawakami and Masaharu Terashima and has published in prestigious journals such as Cancer, Cancer Research and Oncogene.

In The Last Decade

Mikio Igawa

164 papers receiving 4.0k citations

Peers

Countries citing papers authored by Mikio Igawa

Since Specialization

Citations

This map shows the geographic impact of Mikio Igawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Igawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Igawa more than expected).

Fields of papers citing papers by Mikio Igawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikio Igawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Igawa. The network helps show where Mikio Igawa may publish in the future.

Co-authorship network of co-authors of Mikio Igawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mikio Igawa. A scholar is included among the top collaborators of Mikio Igawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikio Igawa. Mikio Igawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How asymptomatic are early cancer patients of five organs based on registry data in Japan 2018 ·International Journal of Clinical Oncology ·(unknown), Masahiro Hirose, Ritsuro Suzuki, Junji Suzumiya, Mikio Igawa	6
2	Magnetic resonance imaging features of angiomyofibroblastoma-like tumor of the scrotum with pathologic correlates 2012 ·Clinical Imaging ·(unknown), Takeshi Yoshizako, Hajime Kitagaki, Asuka Araki, Mikio Igawa	13
3	Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine model 2012 ·British Journal of Urology ·Yozo Mitsui, Hiroaki Shiina, (unknown), Naoko Arichi, Hiroaki Yasumoto, Rajvir Dahiya, Emil A. Tanagho, Mikio Igawa	6
4	UP-03.162 Assessment of Effects of Pelvic Floor Muscle Exercises Performed With Music 2011 ·Urology ·Satoshi Honda, K Inoue, (unknown), Naoko Arichi, Yozo Mitsui, (unknown), Masahiro Sumura, Hiroaki Yasumoto, (unknown), Mikio Igawa	1
5	Current chemotherapeutic strategies against bladder cancer 2011 ·International Urology and Nephrology ·Yozo Mitsui, Hiroaki Yasumoto, Naoko Arichi, Satoshi Honda, Hiroaki Shiina, Mikio Igawa	6
6	A case of primary retroperitoneal serous adenocarcinoma 2011 ·International Journal of Urology ·Naoko Arichi, Hiroaki Yasumoto, Yozo Mitsui, (unknown), Satoshi Honda, Hiroaki Shiina, Mikio Igawa	10
7	Five‐year longitudinal effect of radical perineal prostatectomy on health‐related quality of life in Japanese men, using general and disease‐specific measures 2009 ·British Journal of Urology ·Shogo Inoue, Hiroaki Shiina, (unknown), (unknown), Masahiro Sumura, Satoshi Honda, Shinji Urakami, Mikio Igawa, Tsuguru Usui	15
8	Current use of the artificial urinary sphincter and its long‐term durability: A nationwide survey in Japan 2008 ·International Journal of Urology ·Yoichi Arai, Mineo Takei, Katsuya Nonomura, Shiro Baba, Tomonori Habuchi, Tadashi Matsuda, Satoru Takahashi, Mikio Igawa, Yasuhiro Kaiho, Haruo Nakagawa	14
9	MP-14.04: Evaluation of prostate cancer with real-time tissue elastography based on step-section pathologic analysis after radical prostatectomy 2007 ·Urology ·Masahiro Sumura, Kazushi Shigeno, (unknown), Tatsuaki Yoneda, (unknown), Mikio Igawa	1
10	Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: Histologic and functional evaluation 2005 ·Urology ·Mohamed Youssif, Hiroaki Shiina, Shinji Urakami, Curtis A. Gleason, Lora Nunes, Mikio Igawa, Hideki Enokida, Emil A. Tanagho, Rajvir Dahiya	40
11	Ets protein Elf‐1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair‐related Nth1 gene 2003 ·Molecular Carcinogenesis ·Satoshi Honda, Toshiyuki Kobayashi, Kazunori Kajino, Shinji Urakami, Mikio Igawa, Okio Hino	13
12	Heat–Induced Cellular Damage and Tolerance in Combination with Adriamycin for the PC–3 Prostate Cancer Cell Line: Relationships with Cytotoxicity, Reactive Oxygen Species and Heat Shock Protein 70 Expression 2000 ·European Urology ·(unknown), Mikio Igawa, Hiroaki Shiina, Shinji Urakami, Yoshiaki Wada, Masaharu Terashima	8
13	Clinical Significance of mdm2 and p53 Expression in Bladder Cancer 1999 ·Oncology ·Hiroaki Shiina, Mikio Igawa, Kazushi Shigeno, (unknown), Shinji Urakami, Tatsuaki Yoneda, Yukihiro Wada, Satoshi Honda, Makoto Nagasaki	51
14	Traumatic Dislocation of the Testis 1999 ·Urologia Internationalis ·Hiroshi Yagi, Mikio Igawa, Hiroaki Shiina, Kazushi Shigeno, Tatsuaki Yoneda, Yukihiro Wada	1
15	Evaluation of the ArgyrophilicNucleolar Organizer Region,Nuclear DNA Content and MeanNuclear Area in Transitional CellCarcinoma of Bladder Using aQuantitative Image Analyzer 1996 ·European Urology ·Hiroaki Shiina, Shinji Urakami, Hiroki Shirakawa, Kazushi Shigeno, (unknown), Masami Mizutani, Mikio Igawa, Tomoyuki Ishibe	8
16	Immunohistochemical evaluation of proliferating cell nuclear antigen, prostate‐specific antigen and α1‐antichymotrypsin in human prostate cancer 1996 ·British Journal of Urology ·Mikio Igawa, Shinji Urakami, Hiroaki Shiina, Tomoyuki Ishibe, (unknown), Tatsuya Usui, Gerald W. Chodak	10
17	M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen 1994 ·Cancer Chemotherapy and Pharmacology ·Mikio Igawa, (unknown), (unknown), Tsuguru Usui	1
18	N‐(4‐hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells 1994 ·The Prostate ·Mikio Igawa, (unknown), Gerald W. Chodak, Daniel B. Rukstalis	50
19	Long-Term Results of Endourologic Treatment of Urinary Calculi: Investigation of Risk Factors for Recurrence or Regrowth* 1993 ·Journal of Endourology ·Takahisa Nakamoto, (unknown), Akira Yamasaki, (unknown), S. Fujiwara, Mikio Igawa, (unknown), Tsuguru Usui	11
20	M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced bladder cancer 1990 ·Mikio Igawa, (unknown), (unknown), Masaki Ueda, Kosuke Okada, Tatsuya Usui	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact